Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
63
Total 13F shares, excl. options
13.1M
Shares change
+4.24M
Total reported value, excl. options
$615M
Value change
+$200M
Number of buys
43
Number of sells
-10
Price
$47.15

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2020

69 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q4 2020.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.1M shares of 264M outstanding shares and own 4.94% of the company stock.
Largest 10 shareholders include Cederberg Capital Ltd (1.78M shares), Avidity Partners Management LP (1.59M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (1.5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), Artisan Partners Limited Partnership (857K shares), Ward Ferry Management (BVI) Ltd (753K shares), Artal Group S.A. (725K shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (633K shares), ORBIMED ADVISORS LLC (606K shares), and Octagon Capital Advisors LP (455K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.